Cafepharma Today

January 27 2025 - Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Sage rejects Biogen's $469 million takeover offer, says offer undervalues company
Metsera eyes $289M IPO to fund phase 3 weight loss trial
Biogen, Eisai win nod for monthly Leqembi maintenance amid stagnant sales
Sara Brenner, FDA device official, named agency’s acting head
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Taro Receives FDA Approvals for Ciclopirox Topical Solution, 8% (Nail Lacquer) and Grape Flavor Formulation of Loratadine Syrup, 5mg
Ad Hoc News, Germany
Saturday, February 7, 2009 - 11:11am
tags:
Taro
Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
Trading Markets
Saturday, February 7, 2009 - 11:08am
tags:
Genesis
FDA OKs New GERD Drug Kapidex
WebMD
Saturday, February 7, 2009 - 11:07am
tags:
Kapidex, Takeda
Bill Introduced to Prohibit the Marketing of Authorized Generic Drugs
Patent Baristas
Saturday, February 7, 2009 - 11:05am
tags:
Small drug cos oppose central licensing agency (in India)
Economic Times, India
Saturday, February 7, 2009 - 10:59am
tags:
India
iogen Too Attractive to Ignore
Zacks
Saturday, February 7, 2009 - 10:58am
tags:
Biogen Idec
AstraZeneca Is Speaking Mandarin, Not Merger
Forbes
Saturday, February 7, 2009 - 10:57am
tags:
AstraZeneca
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit Against Rigel Pharmaceuticals, Inc.
Yahoo
Saturday, February 7, 2009 - 10:55am
tags:
Rigel
J&J catheter 1st approved for deadly heart rhythm
Yahoo/AP
Saturday, February 7, 2009 - 10:54am
tags:
JNJ
Here Comes Pharma's 'Me-Too' Mergers
Seeking Alpha
Saturday, February 7, 2009 - 10:52am
tags:
Finkelstein Thompson LLP Announces Investigation Into Indevus Pharmaceuticals
Yahoo
Saturday, February 7, 2009 - 10:51am
tags:
Indevus
Pharm Animals: A Drug from Goat’s Milk Is Just the Start
Wall Street Journal
Saturday, February 7, 2009 - 10:50am
tags:
Biogen's 4Q profit grows as Icahn makes power play
Yahoo
Saturday, February 7, 2009 - 10:50am
tags:
Biogen Idec, Carl Icahn
Report: Glaxo in talks to buy Indian generic maker
Yahoo
Saturday, February 7, 2009 - 10:48am
tags:
GSK, Piramal Healthcare
IPO VIEW-Mead Johnson IPO to build up Bristol Myers cash
Reuters
Friday, February 6, 2009 - 9:52am
tags:
IPOs, Mead Johnson, Bristol-Myers Squibb
[video] Roche CEO Eyes Biotech
Yahoo/CNBC
Friday, February 6, 2009 - 9:46am
tags:
Roche, biotech, Genentech
Procter & Gamble Eyes Exit From Prescription Drugs
WSJ Online
Friday, February 6, 2009 - 9:44am
tags:
Proctor & Gamble, Actonel
Idenix and GSK Partner on HIV Treatment Drug
Seeking Alpha
Friday, February 6, 2009 - 8:55am
tags:
Idenix, GSK, HIV, IDX899
AstraZeneca: One Pharma Giant Not Looking for a Big Deal
WSJ Online
Friday, February 6, 2009 - 8:53am
tags:
AstraZeneca, buyouts
In Pharma Mergers, More Big Biotechs Could Get Gobbled
Yahoo/Businessweek
Friday, February 6, 2009 - 8:23am
tags:
biotech, buyouts, Pfizer, Wyeth, Roche, Genentech, Amgen, Biogen Idec

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information